No profile data available.
Electra Therapeutics, Inc. (ETRA) is a listed company, based in South San Francisco, United States, with about 46 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$61.98 million. Its market capitalization was $567.41 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer.
Electra Therapeutics reported $0 in revenue for fiscal year 2025.
$567.41 million as of October 9, 2026.